Gary Ingenito, MD, PhD, has more than 30 years of experience in the field of pharmaceutical development; including drugs, biologics, devices and combination products. During this time, Dr. Ingenito has held executive responsibilities for clinical research, regulatory affairs, pharmacovigilance, and medical affairs at pharmaceutical companies and contract research organizations. His development and regulatory experience spans multiple therapeutic areas, from early stage products through post-approval, across the US, Europe, and Japan. Most recently, Dr. Ingenito was the Chief Medical and Regulatory Officer at Catalyst Pharmaceuticals, Inc.
Dr. Ingenito holds an undergraduate degree from The Johns Hopkins University, a medical degree from Jefferson Medical College, and a PhD in microbiology/immunology from Thomas Jefferson University. He completed a post-graduate residency in neurology at the University of Miami. Dr. Ingenito is a member of the Board of Directors for the Addario Lung Cancer Medical Institute.